key: cord-0722610-7whaax2f
authors: Eunice, Adegbola Aanuoluwa; Samuel, Fadahunsi Olumide; Alausa, Abdulahi; Zabdiel, Abijo Ayodeji; Adewale, Balogun Toheeb; Sarah, Aderibigbe Taiwo; Banjo, Semire; Ifeoluwa, Adegbola Peter
title: Computational prediction of nimbanal as potential antagonist of respiratory syndrome coronavirus
date: 2021-05-28
journal: Inform Med Unlocked
DOI: 10.1016/j.imu.2021.100617
sha: ab0f6d6199c3dc02bfd751843586717d09a08241
doc_id: 722610
cord_uid: 7whaax2f

The high pathogenic nature of the Middle East Respiratory coronavirus (MER) and the associated high fatality rate demands an urgent attention from researchers. Because there is currently no approved drug for the management of the disease, research efforts have been intensified towards the discovery of a potent drug for the treatment of the disease. Papain Like protease (PLpro) is one of the key proteins involved in the viral replication. We therefore docked forty-six compounds already characterized from Azadirachta indica, Xylopia aethipica and Allium cepa against MERS-CoV-PLpro. The molecular docking analysis was performed with AutoDock 1.5.6 and compounds which exhibit more negative free energy of binding, and low inhibition constant (Ki) with the protein (MERS-CoV-PLpro) were considered potent. The physicochemical and pharmacokinetic properties of the compounds were predicted using the Swissadme web server. Twenty-two of the compounds showed inhibition potential similar to dexamethasone and remdesvir, which had binding affinity of −6.8 and −6.3 kcal/mol respectively. The binding affinity of the compounds ranged between −3.4 kcal/mol and −7.7 kcal/mol whereas; hydroxychloroquine had a binding affinity of −4.5 kcal/mol. Among all the compounds, nimbanal and verbenone showed drug likeliness, they did not violate the Lipinski rule neither were they inhibitors of drug-metabolizing enzymes. Both nimbanal and verbenone were further post-scored with MM/GBSA and the binding free energy of nimbanal (−25.51 kcal/mol) was comparable to that of dexamethasone (−25.46 kcal/mol). The RMSD, RMSF, torsional angle, and other analysis following simulation further substantiate the efficacy of nimbanal as an effective drug candidate. In conclusion, our study showed that nimbanal is a more promising therapeutic agent and could be a lead for the discovery of a new drug that may be useful in the management of severe respiratory coronavirus syndrome.

The Middle East respiratory syndrome coronavirus (MERS-CoV) was discovered to be highly pathogenic with potentials to infect human (Zaki et al., 2012; de Groot et al., 2013) after it was detected in a Saudi Arabia man in 2012 (Chan et al., 2012; Zaki et al., 2012) . Due to international travels of infected people, MERS-CoV has spread worldwide with 2,502 laboratory-confirmed infection cases reported between September 2012 and December 2019 as well as 858 associated deaths (Rut et al., 2020) . In December 2019 a novel coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) formerly known as the 2019 novel coronavirus (2019-nCoV) and similar to SARS-CoV was identified in Wuhan, China Wang et al., 2020) . Although SARS-CoV, MERS-CoV, and SARS-CoV-2 were identified to be highly pathogenic in the human population, there is presently no effective remedy against the virus (Rut et al., 2020) .

The high case-fatality rate (CFR) of MERS-CoV infection far exceeds that of all other known human coronaviruses, including the human severe acute respiratory syndrome coronavirus (SARS-CoV) (Lee et al., 2015) , therefore making it of great concern. J o u r n a l P r e -p r o o f MERS-CoV similar to SARS-CoV is a single-strand positive-sense RNA virus whose large polyprotein is processed by two proteases, i.e. a 3-C-like protease (3CLpro) and a papain-like protease (PLpro) (Lee et al., 2015) . The single MERS-CoV papain-like protease (Harcourt et al., 2004; Thiel et al., 2003) enzyme is part of a large non-structural protein 3 (nsp3) that contain four other domain; a ubiquitin like fold (UB1), an ADP-ribose-1d-phosphatase (ADRP) domain, a SARS-unique domain (SUD), and a transmembrane (TM) domain. PLpro enzyme function in the cleavage of the first three positions of its polyprotein, while 3CLpro cleaves the remaining 11 locations, releasing 16 nonstructural proteins (nsp) in both MERS-CoV and SARS-CoV (Lee et al., 2015) . Aside from the cleavage function, the MERS-PLpro also exhibits deubiquitination and de-ISGylation (Yang et al., 2013; Mielech et al., 2014) . This deubiquitination and de-ISGylation function makes PLpro an interferon antagonist. It blocks the interferon regulatory factor 3 (IRF3) pathway (Mielech et al., 2014; Yang et al., 2014) , and evades the host cells innate immune response ( Yang et al., 2013; Mielech et al., 2014; Clementz et al., 2010) .

The use of plants for the management of various kinds of diseases constitutes great interest globally (Wang et al., 2004) . Many drug-like molecules present in plants are still of value in providing support to human health worldwide (Sejal et al., 2016) . The current attention given to plant derived anti-microbial agents is linked to their safety and elongated history of practice (Stohs and Hartman, 2015) . Azadirachta indica, Xylopia aethipica and Allium cepa have been reported with various biological functions such as antiviral, antibacterial, antimalarial, anticancer and anti-inflammatory ( Biswas et al., 2002; Bouvier et al., 2008; Chen et al., 2011; Corzomartinez et al., 2007; Kumar as Pandy, 2013; Suleria et al., 2015; Xu et al., 2012) .

Therefore, they could serve as a repository of important biological compounds with inhibitory potentials against respiratory syndrome coronavirus. In this study, molecular modelling J o u r n a l P r e -p r o o f techniques that involve the combination of molecular docking, molecular dynamics simulations, MM/GBSA computation, and pharmacokinetics studies were employed for the characterization of target compounds already identified in these plants. These methods put together are robust and will provide a lead for the identification of promising drug candidates.

The three-dimensional structure of MERS-CoV Papain like protease (PLpro) (PDB: 4PT5), was retrieved from the Protein Data Bank (PDB) (https://www.rcsb.org/) and prepared for molecular docking using BIOVIA Discovery Studio 2019. Before docking, the protein was prepared by removing interacting ligands, and water molecules downloaded together with it followed by saving the clean protein in the PDB format.

We obtained compounds already identified in Allium cepa, Azadirachta indica or Xylopia aethiopica through literature search ( 

We retrieved the FASTA sequence of seven viral proteins from the NCBI portal on 30 June 2020 and took the retrieved sequence for multiple sequence alignments. The list of the protein Drug likeliness and Pharmacokinetics prediction of the compounds was achieved computationally using the Swissadme web server (www.swissadme.ch/). The SMILES structure of the screened compounds obtained from the PubChem database was used for the ADME prediction.

We applied the molecular mechanics/Poisson-Boltzmann surface area (MM/GBSA) module integrated with the prime of the Schrodinger suite for the calculation of binding free energy of docked complex output and computed the relative free energy of the ligand complex using the OPLS3 force field, VSGB solvent and the rotamer search algorithm (Prime, 2019).

The binding free energy was extrapolated from the equation below;

)…...Equation 2

Desmond module of Schrodinger software was employed for the molecular dynamics simulation (Schrödinger, 2018) . We selected nimbanal and dexamethasone because of their good binding affinity and pharmacokinetic properties for the MD simulation with OPLS 2005 force field parameters. The docked complexes were centred on the orthorhombic box of the predefined TIP3P water system. The box's volume was minimized, and the net charge of the system was neutralized by incorporating 0.15 M NaCl into each system to model physiological state (Bowers et al., 2006) . The temperature and pressure were kept constant at 300 K and 1.01325 bar using Nose-Hoover thermostat and Martyna-Tobias-Klein barostat methods. Simulation analysis was performed through the NPT ensembles by considering heavy atoms, time intervals, and pressure (Martyna et al., 1992; Zielkiewicz 2005) . 20 ns simulation of the relaxed system were carried out with NPT ensembles, and the long-range electrostatic interactions were computed using the Particle-Mesh-Ewald algorithm. The trajectories were recorded at 4.8 ps intervals, and the protein-ligand interaction, stability, and behaviour was performed using the Desmond simulation interaction diagram in maestro (Schrödinger, 2018; Adelakun et al., 2020) J o u r n a l P r e -p r o o f 3.0

Of the seven proteins, three were of Jordan while the other four were of England origin ( Figure   1 

For the validation of the docking protocol, the root mean square deviation obtained for the ligands before and after docking was close to 1, therefore the docking protocol is correct

The Middle East Respiratory Syndrome coronavirus Papain like protease consist of 324 amino acid sequence with molecular weight of 36.10 kDa. Previous study stated that the protein is made (Table 4 ).

Quercetin-3-glucoside showed stronger affinity for PLpro than others, having binding affinity of 

The drug-attrition rate in preclinical and clinical trials is quite alarming due to poor pharmacokinetic studies (Gurung et al., 2016) . Consequently, initial screening of these drug-like J o u r n a l P r e -p r o o f molecules can increase the chances of passing through the clinics (Gurung et al., 2020) . In this regard, the docked compounds were subjected to in silico ADME screening. The drug-likeness test was based on the Lipinski's Rule of Five (Lipinski et al., 1997 (Table 3b ). In addition, these compounds together with 3-deacetylsalanin and Azadironic acid are highly absorbed by the intestine whereas only Verbenone, Nimbionone, Nimbionol, Nimbolide, Cubebene and Buoebenone, Bornyl acetate, Copaene and

Hydroxychloroquine have blood-brain barrier permeation. The cytochrome P450 enzymes (CYPs) constitute a superfamily of proteins important in the metabolism and detoxification of xenobiotics (Brown et al., 2008) . Inhibition of any of the drug-metabolizing CYPs will elevate the concentration of the corresponding drug substrate and bring about drug overdose (Murray, 2006) . Some of the compounds with probable drug likeliness including hydroxychloroquine and remdesivir were inhibitors to one or more of the metabolizing enzymes. Interestingly, Nimbanal, Nimbolide, Nimocinol and Verbenone were non-inhibitor to any of the metabolizing enzymes, therefore these compounds are potential drug with attractive pharmacokinetic profiles. Pglycoprotein (Pgp) is a critical determinant of the pharmacokinetic properties of drugs as it functions to extracts foreign substances from the cell (Ambudkar et al., 2003) . Nimbanal and Verbenone were predicted to be non P-glycoprotein (Pgp) substrate and therefore appeared to be the only among all to have drug-like potentials.

J o u r n a l P r e -p r o o f 3.4

Measurement of binding strength and affinity of a ligand when it occupies the active region of the protein using thermodynamics calculation will help to understand the nature of existing interaction. (Genheden and Ryde, 2015) . Both verbenone and nimbanal showed interesting pharmacokinetic properties and together with dexamethasone, were post-scored with MM/GBSA. This method of scoring is well established to show a more reliable statistical relationship to experimental binding affinity (Greenidge et al., 2013) . From the MM/GBSA computation, the binding free energy for dexamethasone, nimbanal and verbenone was -25.46, -25.51 and -9.14 kcal/mol respectively ( Figure 10 ). The result further justified that the inhibitory potential of nimbanal was comparable to that of dexamethasone and so, only the two compounds were subjected to molecular dynamics simulation

Nimbanal, among the natural compounds, exhibited drug like characteristics and strong binding affinity, and was selected with dexamethasone for MD simulation. The dynamic simulation was performed for 20 ns, and the dynamics stability of the complexes was analysed using parameters like the L-RMSF, protein-ligand RMSD, protein-ligand contacts, ligand torsion profile, P-RMSF and ligand properties. 

From this study, nimbanal and verbenone appear to be the only compounds with attractive physicochemical and pharmacokinetic properties to qualify as drug-like molecule. In addition, nimbanal appeared to be a good inhibitor for MERS-CoV-PLpro with high binding affinity and low inhibition constant. From our observation, the high binding affinity of nimbanal correlates with it stable interaction with the protein following simulation. However, non nimbanal-protein interaction exhibited might suggest further in-vivo or in-vitro analysis to establish the pharmacological and biological properties of nimbanal. Overall, the simulation result showed that nimbanal is a more promising therapeutic agent in the treatment of severe respiratory syndrome compared to dexamethasone. The favourable interaction of dexamethasone might contribute to its importance in the pool of library of trial drugs. Furthermore, the RMSD, RMSF, torsional angle, and other analysis following simulation demonstrated that nimbanal could be an effective drug candidate. Therefore, it provides a potential lead for the treatment of severe respiratory syndrome.

J o u r n a l P r e -p r o o f 

Availability of data and material (Not applicable)

Authors' contributions (API, SB and AAE conceptualize the study, API, FOS, AA, AZA provided the resources, API and AAE performed the docking study, AAE did the ADMET study, ATS and API performed the BLAST analysis, API, AA, FOS, AZA and BTA did the molecular dynamics study, API and BTA did the MM/GBSA study, API wrote the manuscript, all authors approved the final draft)

Consent for publication (All authors approved the manuscript for publication) 

P glycoprotein: from genomics to mechanism

Biological activities and medicinal properties of neem (Azadirachta indica)

The biology of influenza viruses. Vaccine

Scalable algorithms for molecular dynamics simulations on commodity clusters

Proceedings of the SC 2006 Proceedings Supercomputing

Broad-spectrum antiviral remdesivir inhibits human endemic and zoonotic delta coronaviruses with a highly divergent RNA dependent RNA polymerase

Cytochromes P450: a structure-based summary of biotransformations using representative substrates

Is the discovery of the novel human betacoronavirus 2cEMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

In -vitro anti-adenoviral activity of five Allium plants

Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases

Biological properties of onions and garlic

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the coronavirus study group

The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities

MM/GBSA binding energy prediction on the PDB bind data set: Successes, failures, and directions for further improvement

Molecular docking of the anticancer bioactive compound proceraside with macromolecules involved in the cell cycle and DNA replication

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2Mpro enzyme through in silico approach

Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94

Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV

Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Nosé-Hoover chains: The canonical ensemble via continuous dynamics

MERS-CoV papain-like protease has deISGylating and deubiquitinating activities

Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents

Discovery of new promising USP14 inhibitors: computational evaluation of the thumb-palm pocket

An insilico evaluation of the ADMET profile of the StreptomeDB database

Prime. Schrodinger, LLC

Antiviral activity of Acacia nilotica against hepatitis C virus in liver infected cells

Activity profiling and structures of inhibitor-bound SARS-CoV-2-PLpro protease provides a framework for anti-COVID-19 drug design

Maestro-desmond interoperability tools

A review on a miracle fruits of Annona muricata

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Review of the safety and efficacy of Moringa oleifera

Onion: nature protection against physiological threats

Mechanisms and enzymes involved in SARS coronavirus genome expression

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading

A novel coronavirus outbreak of global health concern

Role of plant heat-shock proteins and molecular Chaperones in the abiotic stress response

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods

Antiviral activity and mode of action of extracts from neem seed kernel against duck plague virus in vitro

Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease

Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Structural Properties of Water: Comparison of the SPC, SPCE, TIP4P, and

J o u r n a l P r e -p r o o f